Skip to main content
Top
Published in: Cancer Causes & Control 10/2010

01-10-2010 | Original paper

A remarkable reduction of breast cancer deaths in screened versus unscreened women: a case-referent study

Authors: Ellen Paap, Roland Holland, Gerard J. den Heeten, Guido van Schoor, Anita A. M. Botterweck, André L. M. Verbeek, Mireille J. M. Broeders

Published in: Cancer Causes & Control | Issue 10/2010

Login to get access

Abstract

Objective

We designed a case-referent study to investigate the effect of mammographic screening at the individual level, looking at the association of breast cancer death with screening history.

Methods

The study population included all women aged 50–75 in the province of Limburg, the Netherlands who had been invited to the screening program from 1989 to 2006. From this population, 118 cases originated who died of breast cancer in 2004 or 2005. The screening history of these cases was collected and compared with a sample of the invited population. The breast cancer death rate in the screened relative to the unscreened women was estimated as the odds ratio (OR). This OR was adjusted for self-selection bias, the difference in baseline risk for breast cancer death between screened and unscreened women.

Results

Analysis of the data showed a breast cancer mortality reduction of 70% in the screened versus the unscreened women (OR = 0.30, 95% CI 0.14–0.63). The magnitude of self-selection was estimated specifically for Limburg. After correction for self-selection bias, the effect of screening increased to 76% (OR = 0.24, 95% CI 0.10–0.58).

Conclusion

Screening resulted in a remarkable reduction in breast cancer mortality. Contrary to findings in other countries, adjustment for self-selection in Limburg had no influence on the impact of screening. Thanks to a well-organized centralized screening program, similar results are expected in other regions of the Netherlands.
Literature
1.
go back to reference IARC Handbooks of Cancer Prevention (2002) Breast Cancer Screening, vol 7. Lyon, IARC IARC Handbooks of Cancer Prevention (2002) Breast Cancer Screening, vol 7. Lyon, IARC
2.
go back to reference Holland R, Rijken H, Hendriks JHCL (2007) The Dutch population-based mammography screening: 30-year experience. Breast Care 2:12–18CrossRef Holland R, Rijken H, Hendriks JHCL (2007) The Dutch population-based mammography screening: 30-year experience. Breast Care 2:12–18CrossRef
3.
go back to reference Otten JD, Broeders MJ, Fracheboud J, Otto SJ, de Koning HJ, Verbeek AL (2008) Impressive time-related influence of the Dutch screening programme on breast cancer incidence, mortality, 1975–2006. Int J Cancer 123:1929–1934CrossRefPubMed Otten JD, Broeders MJ, Fracheboud J, Otto SJ, de Koning HJ, Verbeek AL (2008) Impressive time-related influence of the Dutch screening programme on breast cancer incidence, mortality, 1975–2006. Int J Cancer 123:1929–1934CrossRefPubMed
4.
go back to reference Fracheboud J, Otto SJ, van Dijck JA, Broeders MJ, Verbeek AL, de Koning HJ (2004) Decreased rates of advanced breast cancer due to mammography screening in The Netherlands. Br J Cancer 91:861–867PubMed Fracheboud J, Otto SJ, van Dijck JA, Broeders MJ, Verbeek AL, de Koning HJ (2004) Decreased rates of advanced breast cancer due to mammography screening in The Netherlands. Br J Cancer 91:861–867PubMed
5.
go back to reference Vervoort MM, Draisma G, Fracheboud J, Poll-Franse LV, de Koning HJ (2004) Trends in the usage of adjuvant systemic therapy for breast cancer in the Netherlands and its effect on mortality. Br J Cancer 91:242–247PubMed Vervoort MM, Draisma G, Fracheboud J, Poll-Franse LV, de Koning HJ (2004) Trends in the usage of adjuvant systemic therapy for breast cancer in the Netherlands and its effect on mortality. Br J Cancer 91:242–247PubMed
6.
go back to reference Sasco AJ, Day NE, Walter SD (1986) Case-control studies for the evaluation of screening. J Chronic Dis 39:399–405CrossRefPubMed Sasco AJ, Day NE, Walter SD (1986) Case-control studies for the evaluation of screening. J Chronic Dis 39:399–405CrossRefPubMed
7.
go back to reference Allgood PC, Warwick J, Warren RM, Day NE, Duffy SW (2007) A case-control study of the impact of the East Anglian breast screening programme on breast cancer mortality. Br J Cancer 98:206–209CrossRefPubMed Allgood PC, Warwick J, Warren RM, Day NE, Duffy SW (2007) A case-control study of the impact of the East Anglian breast screening programme on breast cancer mortality. Br J Cancer 98:206–209CrossRefPubMed
8.
go back to reference Broeders MJ, Verbeek AL (2005) Mammographic screening only matters in the detectable preclinical period of breast cancer. J Med Screen 12:107CrossRefPubMed Broeders MJ, Verbeek AL (2005) Mammographic screening only matters in the detectable preclinical period of breast cancer. J Med Screen 12:107CrossRefPubMed
9.
go back to reference Weiss NS, McKnight B, Stevens NG (1992) Approaches to the analysis of case-control studies of the efficacy of screening for cancer. Am J Epidemiol 135:817–823PubMed Weiss NS, McKnight B, Stevens NG (1992) Approaches to the analysis of case-control studies of the efficacy of screening for cancer. Am J Epidemiol 135:817–823PubMed
10.
go back to reference Kleinbaum DG (1994) Logistic regression: a self-learning text. Springer, New York, p 227 Kleinbaum DG (1994) Logistic regression: a self-learning text. Springer, New York, p 227
11.
go back to reference Cronin KA, Weed DL, Connor RJ, Prorok PC (1998) Case-control studies of cancer screening: theory and practice. J Natl Cancer Inst 90:498–504CrossRefPubMed Cronin KA, Weed DL, Connor RJ, Prorok PC (1998) Case-control studies of cancer screening: theory and practice. J Natl Cancer Inst 90:498–504CrossRefPubMed
12.
go back to reference O’Byrne AM, Kavanagh AM, Ugoni A, Diver F (2000) Predictors of non-attendance for second round mammography in an Australian mammographic screening programme. J Med Screen 7:190–194CrossRefPubMed O’Byrne AM, Kavanagh AM, Ugoni A, Diver F (2000) Predictors of non-attendance for second round mammography in an Australian mammographic screening programme. J Med Screen 7:190–194CrossRefPubMed
13.
go back to reference Roder D, Houssami N, Farshid G et al (2008) Population screening and intensity of screening are associated with reduced breast cancer mortality: evidence of efficacy of mammography screening in Australia. Breast Cancer Res Treat 108:409–416CrossRefPubMed Roder D, Houssami N, Farshid G et al (2008) Population screening and intensity of screening are associated with reduced breast cancer mortality: evidence of efficacy of mammography screening in Australia. Breast Cancer Res Treat 108:409–416CrossRefPubMed
14.
go back to reference Zackrisson S, Andersson I, Manjer J, Janzon L (2004) Non-attendance in breast cancer screening is associated with unfavourable socio-economic circumstances and advanced carcinoma. Int J Cancer 108:754–760CrossRefPubMed Zackrisson S, Andersson I, Manjer J, Janzon L (2004) Non-attendance in breast cancer screening is associated with unfavourable socio-economic circumstances and advanced carcinoma. Int J Cancer 108:754–760CrossRefPubMed
15.
go back to reference Paci E, Duffy SW, Giorgi D et al (2002) Quantification of the effect of mammographic screening on fatal breast cancers: The Florence Programme 1990–96. Br J Cancer 87:65–69CrossRefPubMed Paci E, Duffy SW, Giorgi D et al (2002) Quantification of the effect of mammographic screening on fatal breast cancers: The Florence Programme 1990–96. Br J Cancer 87:65–69CrossRefPubMed
16.
go back to reference Duffy SW, Cuzick J, Tabár L et al (2002) Correcting for non-compliance bias in case-control studies to evaluate cancer screening programmes. Appl Stat 51(2):235–243 Duffy SW, Cuzick J, Tabár L et al (2002) Correcting for non-compliance bias in case-control studies to evaluate cancer screening programmes. Appl Stat 51(2):235–243
17.
go back to reference Fielder HM, Warwick J, Brook D et al (2004) A case-control study to estimate the impact on breast cancer death of the breast screening programme in Wales. J Med Screen 11:194–198CrossRefPubMed Fielder HM, Warwick J, Brook D et al (2004) A case-control study to estimate the impact on breast cancer death of the breast screening programme in Wales. J Med Screen 11:194–198CrossRefPubMed
18.
go back to reference Schopper D, de Wolf C (2009) How effective are breast cancer screening programmes by mammography? Review of the current evidence. Eur J Cancer 45:1916–1923CrossRefPubMed Schopper D, de Wolf C (2009) How effective are breast cancer screening programmes by mammography? Review of the current evidence. Eur J Cancer 45:1916–1923CrossRefPubMed
19.
go back to reference Gabe R, Tryggvadottir L, Sigfusson BF, Olafsdottir GH, Sigurdsson K, Duffy SW (2007) A case-control study to estimate the impact of the Icelandic population-based mammography screening program on breast cancer death. Acta Radiol 48:948–955CrossRefPubMed Gabe R, Tryggvadottir L, Sigfusson BF, Olafsdottir GH, Sigurdsson K, Duffy SW (2007) A case-control study to estimate the impact of the Icelandic population-based mammography screening program on breast cancer death. Acta Radiol 48:948–955CrossRefPubMed
20.
go back to reference Puliti D, Miccinesi G, Collina N et al (2008) Effectiveness of service screening: a case-control study to assess breast cancer mortality reduction. Br J Cancer 99:423–427CrossRefPubMed Puliti D, Miccinesi G, Collina N et al (2008) Effectiveness of service screening: a case-control study to assess breast cancer mortality reduction. Br J Cancer 99:423–427CrossRefPubMed
21.
go back to reference Aro AR, de Koning HJ, Absetz P, Schreck M (2001) Two distinct groups of non-attenders in an organized mammography screening program. Breast Cancer Res Treat 70:145–153CrossRefPubMed Aro AR, de Koning HJ, Absetz P, Schreck M (2001) Two distinct groups of non-attenders in an organized mammography screening program. Breast Cancer Res Treat 70:145–153CrossRefPubMed
22.
go back to reference Bare ML, Montes J, Florensa R, Sentis M, Donoso L (2003) Factors related to non-participation in a population-based breast cancer screening programme. Eur J Cancer Prev 12:487–494CrossRefPubMed Bare ML, Montes J, Florensa R, Sentis M, Donoso L (2003) Factors related to non-participation in a population-based breast cancer screening programme. Eur J Cancer Prev 12:487–494CrossRefPubMed
23.
go back to reference Hartman E, van den Muijsenbergh ME, Haneveld RW (2009) Breast cancer screening participation among Turks and Moroccans in the Netherlands: exploring reasons for nonattendance. Eur J Cancer Prev 18:349–353CrossRefPubMed Hartman E, van den Muijsenbergh ME, Haneveld RW (2009) Breast cancer screening participation among Turks and Moroccans in the Netherlands: exploring reasons for nonattendance. Eur J Cancer Prev 18:349–353CrossRefPubMed
24.
go back to reference Visser O, van der Kooy K, van Peppen AM, Ory FG, van Leeuwen FE (2004) Breast cancer risk among first-generation migrants in the Netherlands. Br J Cancer 90:2135–2137PubMed Visser O, van der Kooy K, van Peppen AM, Ory FG, van Leeuwen FE (2004) Breast cancer risk among first-generation migrants in the Netherlands. Br J Cancer 90:2135–2137PubMed
25.
go back to reference Zahl PH, Maehlen J, Welch HG (2008) The natural history of invasive breast cancers detected by screening mammography. Arch Intern Med 168:2311–2316CrossRefPubMed Zahl PH, Maehlen J, Welch HG (2008) The natural history of invasive breast cancers detected by screening mammography. Arch Intern Med 168:2311–2316CrossRefPubMed
26.
go back to reference Jorgensen KJ, Gotzsche PC (2009) Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. BMJ 339:b2587CrossRefPubMed Jorgensen KJ, Gotzsche PC (2009) Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. BMJ 339:b2587CrossRefPubMed
Metadata
Title
A remarkable reduction of breast cancer deaths in screened versus unscreened women: a case-referent study
Authors
Ellen Paap
Roland Holland
Gerard J. den Heeten
Guido van Schoor
Anita A. M. Botterweck
André L. M. Verbeek
Mireille J. M. Broeders
Publication date
01-10-2010
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 10/2010
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-010-9585-7

Other articles of this Issue 10/2010

Cancer Causes & Control 10/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine